← Back to Search

Dicarboxylic Acids

Azelaic Acid for Melanosis

Phase 4
Waitlist Available
Led By Valerie D Callender, MD
Research Sponsored by Callender Center for Clinical Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

The purpose of this study is to compare the safety and effectiveness of Azelaic Acid Gel to Hydroquinone Cream in the treatment of melasma.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improvement of melasma

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Azelaic AcidExperimental Treatment1 Intervention
Group II: HydroquinoneActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Callender Center for Clinical ResearchLead Sponsor
3 Previous Clinical Trials
104 Total Patients Enrolled
Valerie D Callender, MDPrincipal InvestigatorHoward University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
New York
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

I'm sure hydroquinone made things worse. I would welcome a treatment that incorporated gene mapping, an inside approach may give better clues however, the opportunity to try something promising is also a consideration.
PatientReceived 1 prior treatment
~2 spots leftby Apr 2025